Viewing data from:

ITRACONAZOLE

ANDA

ITRACONAZOLE | A205080 | AMNEAL PHARMACEUTICALS

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: SPORANOX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.9029

per ea

Lowest NADAC/Unit

$0.9029

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60687029925ITRACONAZOLE 100 MG CAPSULE	$0.9029	EA	Generic	—	2026-08-19
50268045012ITRACONAZOLE 100 MG CAPSULE	$0.9029	EA	Generic	—	2026-08-19
65162063003ITRACONAZOLE 100 MG CAPSULE	$0.9029	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain11 active DMFs6 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

JANSSEN PHARMACEUTICA NVITRACONAZOLE (R051211) DRUG SUBSTANCE

DMF 107251994

W R GRACE AND CO -CONNITRACONAZOLE USP & PH EUR

DMF 126971997

QUIMICA SINTETICA SAITRACONAZOLE

DMF 130121998

NEULAND LABORATORIES LTDITRACONAZOLE USP

DMF 154452001

MATRIX PHARMACORP PRIVATE LTDITRACONAZOLE USP

DMF 177392004

ALIVUS LIFE SCIENCES LTDITRACONAZOLE USP

DMF 179462004

SMS PHARMACEUTICALS LTDITRACONAZOLE USP

DMF 255142011

COHANCE LIFESCIENCES LTDITRACONAZOLE USP

DMF 259862012

MURLI KRISHNA PHARMA PVT LTDITRACONAZOLE PELLETS 22.0 % W/W

DMF 274102013

VASUDHA PHARMA CHEM LTDITRACONAZOLE USP

DMF 352612020

LEE PHARMA LTDITRACONAZOLE USP

DMF 414562025

QUIMICA FINA FARMEX SA DE CVInactiveITRACONAZOLE

DMF 145071999

HETERO DRUGS LTDInactiveITRACONAZOLE

DMF 157282001

PIRAMAL HEALTHCARE LTDInactiveITRACONAZOLE

DMF 169052003

APOTECNIA SAInactiveITRACONAZOLE

DMF 172922004

SOCIETA ITALIANA MEDICINALI SCANDICCIInactiveITRACONAZOLE

DMF 179212004

ALP PHARM BEIJING CO LTDInactiveITRACONAZOLE (DRUG SUBSTANCE, NON-STERILE)

DMF 236412010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Sep 26, 2016

No patent or exclusivity listings for this strength.